These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21323852)

  • 21. Cost-effectiveness of dual-energy X-ray absorptiometry plus antiresorptive treatment in Australian women with breast cancer who receive aromatase inhibitors.
    Sowa PM; Downes MJ; Gordon LG
    J Bone Miner Metab; 2017 Mar; 35(2):199-208. PubMed ID: 26969395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Application of guidelines for secondary prevention of fracture and the FRAX index in patients with fragility fracture].
    Naranjo A; Ojeda-Bruno S; Francisco-Hernández F; Erausquin C; Rúa-Figueroa I; Rodríguez-Lozano C
    Med Clin (Barc); 2011 Mar; 136(7):290-2. PubMed ID: 21185575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Absolute risk for fracture and WHO guideline. Fracture risk assessments recommended by World Health Organization and Japanese guidelines for prevention and treatment of osteoporosis 2006].
    Nakamura T;
    Clin Calcium; 2007 Jul; 17(7):1022-8. PubMed ID: 17607068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Efficacy of densitometry and fracture risk assessment tool FRAX in making therapeutic decisions in osteoporosis--a study on female patients of university of medical sciences endocrinology outpatient clinic].
    Ignaszak-Szczepaniak M; Dytfeld J; Michalak M; Gowin E; Horst-Sikorska W
    Ginekol Pol; 2009 Jun; 80(6):424-31. PubMed ID: 19642598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Digital X-ray radiogrammetry in the study of osteoporotic fractures: Comparison to dual energy X-ray absorptiometry and FRAX.
    Kälvesten J; Lui LY; Brismar T; Cummings S
    Bone; 2016 May; 86():30-5. PubMed ID: 26921822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct comparison of eight national FRAX® tools for fracture prediction and treatment qualification in Canadian women.
    Leslie WD; Brennan SL; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA
    Arch Osteoporos; 2013; 8():145. PubMed ID: 23929269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population trends in BMD testing, treatment, and hip and wrist fracture rates: are the hip fracture projections wrong?
    Jaglal SB; Weller I; Mamdani M; Hawker G; Kreder H; Jaakkimainen L; Adachi JD
    J Bone Miner Res; 2005 Jun; 20(6):898-905. PubMed ID: 15883628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An update on dual-energy x-ray absorptiometry.
    Blake GM; Fogelman I
    Semin Nucl Med; 2010 Jan; 40(1):62-73. PubMed ID: 19958851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of bone mineral density measurement on fracture risk assessment tool® scores in postmenopausal Indian women.
    Daswani B; Desai M; Mitra S; Gavali S; Patil A; Kukreja S; Khatkhatay MI
    Post Reprod Health; 2016 Mar; 22(1):20-4. PubMed ID: 26826081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of patient profile for treatment.
    Moon RJ; Harvey NC
    Best Pract Res Clin Endocrinol Metab; 2014 Dec; 28(6):767-82. PubMed ID: 25432351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positive effects of exercise on falls and fracture risk in osteopenic women.
    Hourigan SR; Nitz JC; Brauer SG; O'Neill S; Wong J; Richardson CA
    Osteoporos Int; 2008 Jul; 19(7):1077-86. PubMed ID: 18188658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imputation of 10-year osteoporotic fracture rates from hip fractures: a clinical validation study.
    Leslie WD; Lix LM;
    J Bone Miner Res; 2010 Feb; 25(2):388-92. PubMed ID: 19653809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of osteopenic women at high risk of fracture: the OFELY study.
    Sornay-Rendu E; Munoz F; Garnero P; Duboeuf F; Delmas PD
    J Bone Miner Res; 2005 Oct; 20(10):1813-9. PubMed ID: 16160738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency of FRAX risk factors in osteopenic postmenopausal women with and without history of fragility fracture.
    Baró F; Cano A; Sánchez Borrego R; Ferrer J; González Rodríguez SP; Neyro JL; Rodriguez Bueno E; Sancho C; Inaraja V; Fernández C; Corral C;
    Menopause; 2012 Nov; 19(11):1193-9. PubMed ID: 22948137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale of the Spanish FRAX model in decision-making for predicting osteoporotic fractures: an update of FRIDEX cohort of Spanish women.
    Azagra R; Zwart M; Encabo G; Aguyé A; Martin-Sánchez JC; Puchol-Ruiz N; Gabriel-Escoda P; Ortiz-Alinque S; Gené E; Iglesias M; Moriña D; Diaz-Herrera MA; Utzet M; Manresa JM;
    BMC Musculoskelet Disord; 2016 Jun; 17():262. PubMed ID: 27317560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteoporosis management program decreases incidence of hip fracture in patients with prostate cancer receiving androgen deprivation therapy.
    Zhumkhawala AA; Gleason JM; Cheetham TC; Niu F; Loo RK; Dell RM; Jacobsen SJ; Chien GW
    Urology; 2013 May; 81(5):1010-5. PubMed ID: 23490521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defining bone health and fracture risk in West Virginia: the World Health Organization FRAX assessment tool.
    Shuler FD; Conjeski J
    W V Med J; 2011; 107(5):12-7. PubMed ID: 22034804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Osteoporosis: prevention of bone loss and fractures].
    Pfeifer M; Begerow B; Pollähne W; Minne HW
    MMW Fortschr Med; 2002 Nov; 144(48):I-VIII; quiz IX-X. PubMed ID: 12532553
    [No Abstract]   [Full Text] [Related]  

  • 39. Ten-year probability of osteoporotic fracture in 2012 Polish women assessed by FRAX and nomogram by Nguyen et al.-Conformity between methods and their clinical utility.
    Pluskiewicz W; Adamczyk P; Franek E; Leszczynski P; Sewerynek E; Wichrowska H; Napiorkowska L; Kostyk T; Stuss M; Stepien-Klos W; Golba KS; Drozdzowska B
    Bone; 2010 Jun; 46(6):1661-7. PubMed ID: 20156606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The characteristics of osteoporotic fractures in the region of Bialystok (BOS-2). The application of the WHO algorithm, FRAX®BMI and FRAX®BMD assessment tools to determine patients for intervention.
    Badurski J; Jeziernicka E; Dobreńko A; Nowak N; Daniluk S; Rybaczuk M; Wiśniowiecka M
    Endokrynol Pol; 2011; 62(4):290-8. PubMed ID: 21879467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.